城市网

纳斯达克生物科技指数收跌0.73%,研究结果欠佳的癫痫疗法概念股Ovid跌76%

导读 成分股Ovid Therapeutics收跌76.00%,Cabaletta Bio、Humacyte、Tourmaline Bio、Prime Medicine跌12.20%-10.69%,Biomea Fusion也跌9...

成分股Ovid Therapeutics收跌76.00%,Cabaletta Bio、Humacyte、Tourmaline Bio、Prime Medicine跌12.20%-10.69%,Biomea Fusion也跌9.75%;万基遗传(MYGN)则收涨3.58%,Cogent Biosciences涨4.45%,Tango Therapeutics涨5.04%,Verona Pharma ADR涨10.04%,Mirum Pharmaceuticals也涨27.31%。

文章转载自:互联网,非本站原创